Pieris Pharmaceuticals, Inc. (PIRS) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 153.02M |
| Enterprise Value | 95.67M |
| P/E Ratio | -27.85 |
| PEG Ratio | 7.84 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 11.25 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -28.35 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.31 |
| Return On Equity | -0.44 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | 0 |
| Net Income | -41.72M |
| Diluted EPS | -3.71 |
| Total Cash | 236.68M |
| Total Cash/Share | 16.29 |
| Total Debt | 485,000 |
| Total Debt/Equity | 0 |
| Current Ratio | 16.01 |
| Book Value Per Share | 13.62 |
| 52-Week Change | -4.96 |
| 52-Week High | 22.32 |
| 52-Week Low | 6.2 |
| Moving Average 50 Days | 16.46 |
| Moving Average 200 Days | 14.03 |
| Average Volume | 22,126 |
| Shares Outstanding | 1.32M |
| % Held by Institutions | 0.13 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:80 |
| Last Split Date | April 23, 2024 |